Compare TLX & SMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLX | SMG |
|---|---|---|
| Founded | 2015 | 1868 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.3B |
| IPO Year | N/A | N/A |
| Metric | TLX | SMG |
|---|---|---|
| Price | $9.02 | $57.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $21.00 | ★ $69.50 |
| AVG Volume (30 Days) | 115.0K | ★ 734.2K |
| Earning Date | 01-01-0001 | 01-28-2026 |
| Dividend Yield | N/A | ★ 4.57% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.04 | ★ 2.47 |
| Revenue | $664,225,558.00 | ★ $3,413,100,000.00 |
| Revenue This Year | N/A | $1.34 |
| Revenue Next Year | N/A | $2.23 |
| P/E Ratio | $284.97 | ★ $23.38 |
| Revenue Growth | ★ 55.35 | N/A |
| 52 Week Low | $8.76 | $45.61 |
| 52 Week High | $30.36 | $79.12 |
| Indicator | TLX | SMG |
|---|---|---|
| Relative Strength Index (RSI) | 38.74 | 58.29 |
| Support Level | $9.37 | $52.06 |
| Resistance Level | $10.03 | $57.23 |
| Average True Range (ATR) | 0.25 | 1.67 |
| MACD | -0.00 | 0.18 |
| Stochastic Oscillator | 7.65 | 87.48 |
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
Scotts Miracle-Gro is the largest purveyor of home lawn and gardening products in the US. The business consists of three reporting segments: US consumer, Hawthorne, and other. The US consumer segment consists of a broad range of lawncare products, including grass seed, fertilizer, and lawn-related weed, animal, and disease control. US consumer typically generates the vast majority of companywide revenue and profits. Hawthorne sells indoor gardening and hydroponic equipment, particularly to the cannabis growing industry, while the other segment primarily consists of lawn and gardening products sold in Canada. Its lawncare and gardening products are well-recognized brands in the US, including Scotts, Miracle-Gro, Roundup, Ortho, and Tomcat.